Various multigene assays have been developed in an attempt to more accurately identify patients with ER+ breast cancer who will benefit from chemotherapy. Oncotype DX (Genomic Health, Redwood City, CA ...

Metaplastic breast carcinoma is a rare heterogeneous category of breast cancer, often associated with a poor prognosis. Clinical-pathologic studies with respect to varied morphologic subtypes are ...